Ping Zhang, PhD

Articles

May 23rd 2013

Medical Costs Associated With Type 2 Diabetes Complications and Comorbidities

Rui Li, PhD Dori Bilik, MBA Morton B. Brown, PhD Ping Zhang, PhD Susan L. Ettner, PhD Ronald T. Ackermann, MD Jesse C. Crosson, PhD William H. Herman, MD

A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.

March 13th 2013

Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants

William H. Herman, MD, MPH Sharon L. Edelstein, ScM Robert E. Ratner, MD Maria G. Montez, RN, MSHP Ronald T. Ackermann, MD, MPH Trevor J. Orchard, MD Mary A. Foulkes, PhD Ping Zhang, PhD Christopher D. Saudek, MD&dagger Morton B. Brown, PhD The Diabetes Prevention Program Research Group

Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.